Physicians' financial ties with the pharmaceutical industry : a critical element of a formidable marketing network
In Don A. Moore (ed.), Conflicts of Interest: Challenges and Solutions in Business, Law, Medicine, and Public Policy. Cambridge University Press. pp. 133 (2005)
AbstractThis article has no associated abstract. (fix it)
Similar books and articles
Understanding Physician-Pharmaceutical Industry Interactions: A Concise Guide.Shaili Jain - 2007 - Cambridge University Press.
Attitudes of academic and clinical researchers toward financial ties in research: A systematic review.Bonnie E. Glaser & Lisa A. Bero - 2005 - Science and Engineering Ethics 11 (4):553-573.
Physicians and the Pharmaceutical Industry: A Reappraisal of Marketing Codes of Conduct.Thomas A. Hemphill - 2006 - Business and Society Review 111 (3):323-336.
From evidence-based medicine to marketing-based medicine: Evidence from internal industry documents. [REVIEW]Glen I. Spielmans & Peter I. Parry - 2010 - Journal of Bioethical Inquiry 7 (1):13-29.
Dangerous Medicine: The Pharmaceutical Industry's Questionable Ethical Practices.John T. Fielding - unknown
On the Take: How America's Complicity with Big Business Can Endanger Your Health.Jerome P. Kassirer - 2005 - Oxford University Press.
Characteristics of physicians receiving large payments from pharmaceutical companies and the accuracy of their disclosures in publications: an observational study. [REVIEW]Susan L. Norris, Haley K. Holmer, Lauren A. Ogden, Brittany U. Burda & Rongwei Fu - 2012 - BMC Medical Ethics 13 (1):24-.
Pharmaceutical Speakers' Bureaus, Academic Freedom, and the Management of Promotional Speaking at Academic Medical Centers.Marcia M. Boumil, Emily S. Cutrell, Kathleen E. Lowney & Harris A. Berman - 2012 - Journal of Law, Medicine and Ethics 40 (2):311-325.
Codes of Business Conduct: Pharma Marketing at a Brossroads?Jayraj Jadeja, Bharat R. Shah & Preshth Bhardwaj - 2005 - International Corporate Responsibility Series 2:359-374.
Of mugs, meals and more: the intricate relations between physicians and the medical industry. [REVIEW]Stephan Sahm - 2013 - Medicine, Health Care and Philosophy 16 (2):265-273.
Bias in the Evaluation of Conflict of Interest Policies.Zachariah Sharek, Robert E. Schoen & George Loewenstein - 2012 - Journal of Law, Medicine and Ethics 40 (2):368-382.
Ethical considerations in the use of direct-to-consumer advertising and pharmaceutical promotions: The impact on pharmaceutical sales and physicians. [REVIEW]R. Stephen Parker & Charles E. Pettijohn - 2003 - Journal of Business Ethics 48 (3):279-290.
Added to PP
Historical graph of downloads